Absorption |
Blood-Brain Barrier | BBB+ | 0.9851 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8573 |
P-glycoprotein Substrate | Non-substrate | 0.8186 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9464 |
Non-inhibitor | 0.9572 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8283 |
Distribution |
Subcellular localization | Mitochondria | 0.8051 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7996 |
CYP450 2D6 Substrate | Non-substrate | 0.8332 |
CYP450 3A4 Substrate | Non-substrate | 0.6988 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8521 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.5682 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9495 |
CYP450 2C19 Inhibitor | Inhibitor | 0.7405 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9357 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6961 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9484 |
Non-inhibitor | 0.8566 |
AMES Toxicity | Non AMES toxic | 0.8578 |
Carcinogens | Carcinogens | 0.5281 |
Fish Toxicity | High FHMT | 0.9910 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9997 |
Honey Bee Toxicity | High HBT | 0.7176 |
Biodegradation | Not ready biodegradable | 0.9590 |
Acute Oral Toxicity | III | 0.7168 |
Carcinogenicity (Three-class) | Non-required | 0.6104 |